2019
DOI: 10.1186/s12935-019-1068-7
|View full text |Cite
|
Sign up to set email alerts
|

TGF-β1 stimulates epithelial–mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer

Abstract: BackgroundThe progression of ductal carcinoma in situ (DCIS) into invasive ductal carcinoma (IDC) is prevented by normal breast myoepithelial cells. Studies have suggested that EMT-associated genes were enriched in IDC in contrast to DCIS. This paper explored the relationship and potential mechanism between myoepithelial cells and EMT-associated genes in facilitating the transformation from DCIS to breast cancer.MethodsEMT markers and myoepithelial phenotypic markers in IDC, DCIS, and healthy breast tissue wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 30 publications
3
8
0
Order By: Relevance
“…In culture and in vivo studies identified that myoepithelial cell expression of integrin β6 enhanced breast tumour cell invasion through TGFβ-mediated upregulation of MMP9 36 . In support of our previous work, others have demonstrated, using in vitro studies, that tumour-associated myoepithelial cells secrete TGFβ to promote the invasive progression of DCIS cells due to enhancing epithelial-to-mesenchymal transition and basal-like phenotypes through activation of the TGFβ/SMAD signalling pathway 37 , 38 . However, the mechanisms inducing such alterations to DCIS myoepithelial cells are largely unknown.…”
Section: Introductionsupporting
confidence: 76%
“…In culture and in vivo studies identified that myoepithelial cell expression of integrin β6 enhanced breast tumour cell invasion through TGFβ-mediated upregulation of MMP9 36 . In support of our previous work, others have demonstrated, using in vitro studies, that tumour-associated myoepithelial cells secrete TGFβ to promote the invasive progression of DCIS cells due to enhancing epithelial-to-mesenchymal transition and basal-like phenotypes through activation of the TGFβ/SMAD signalling pathway 37 , 38 . However, the mechanisms inducing such alterations to DCIS myoepithelial cells are largely unknown.…”
Section: Introductionsupporting
confidence: 76%
“…These conflicting results might be due to the observation that MCF7 differentially expresses TGF-β receptor II depending on the cell passage number and the downregulation of Sp1 [44,45]. Notably, consistent with our findings, many studies have reported that TGF-β1 does induce EMT and migration in MCF7 [46][47][48].…”
Section: Tgf-β1 Pathway Mediates the Recruitment Of Less Aggressive C...supporting
confidence: 59%
“…Analysis of humoral factors mediating the interrelation between tumor cells and fibroblasts within the tumor microenvironment has been reported for several carcinomas such as breast cancer 18 , prostate cancer 19 , and lung cancer. There have been many studies on the relationship with normal cells in epithelial tumors, in cancer-related fibroblasts where fibroblasts acquire the properties of mesenchymal cells 20 22 . In addition, the number of studies described the effects of humoral factors on immune cells.…”
Section: Discussionmentioning
confidence: 99%